Gerald B. Appel
Columbia University Irving Medical Center · 342 works · 32,028 citations · h-index 90
Top works
- The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
- The classification of glomerulonephritis in systemic lupus erythematosus revisited
- Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- RENAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
- The Nephrotoxicity of Antimicrobial Agents
- Long-term follow-up of patients with lupus nephritis
- Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate
- Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease)
- Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
- Diagnostic Utility of Exome Sequencing for Kidney Disease
- C3 glomerulopathy: consensus report
- Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
- Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
- Lipid abnormalities in renal disease
- Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial
- Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis
- Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens
- Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials